This table provides information concerning bioavailability differences between capsule/tablet and liquid/chewable dosage forms of antiretrovirals. Its purpose is to assist providers with management of pregnant patients with HIV who are unable to swallow antiretroviral tablets/capsules.
| Attachment | Size |
|---|---|
| Liquid and Chewable ARVs Table474.56 KB | 474.56 KB |